Percutaneous tumor ablation: Microencapsulated echo-guided interstitial chemotherapy combined with cryosurgery increases necrosis in prostate cancer

Technology in Cancer Research and Treatment

Volumn 8, Issue 3, 2009, Pages 207-216

  Le Pivert, Patrick J ^a   Morrison, Dennis R ^b   Haddad, Ruwaida S ^c   Renard, Michel ^d   Aller, Alex ^e   Titus, Kerry ^e   Doulat, Jacques ^d  

^a NuVueTherapeutics   (United States)

^b KRUG Life Sciences Inc   (United States)

^c NASA JOHNSON SPACE CENTER   (United States)

^d Residence Amphitea   (France)

^e NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

5 FU microencapsulation; Bioluminescence; Cryochemotherapy; Hormone refractory prostate tumor; Interstitial chemotherapy; Ultrasound

Indexed keywords

ETHIODIZED OIL; FLUOROURACIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CANCER GRAFT; CONTROLLED STUDY; CRYOSURGERY; DRUG IMPLANTATION; HUMAN; HUMAN CELL; MALE; MICROENCAPSULATION; MOUSE; NONHUMAN; NUDE MOUSE; PROSTATE CANCER; SUSTAINED DRUG RELEASE; TUMOR NECROSIS; ULTRASOUND;

EID: 66049101690     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460900800305     Document Type: Article

References (23)

1. Onik, G. Image-Guided Prostate Cryosurgery: State of the Art. Cancer Control 8, 522-531 (2001).
2. Katz, A. and Rewcastle, J. The current and Potential Role of Cryoablation as a Primary Therapy for Localized Prostate Cancer. Current Oncology Reports 5, 231-238 (2003). (Pubitemid 38898787)
3. De La Taille, A., Benson, M., Bagiella, E., Burchardt, M., Shabsigh, A., Olsson, C., Katz, A. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. BJU 85, 281-286 (2000). (Pubitemid 30088519)
4. Znati, C. A., Werts, E., Kociban, D., Kalnicki, S. Variables influencing response of human prostate carcinoma cells to combined radiation and Cryotherapy in vitro. Cryobiology 37, 450-451 (1998).
5. Han, B., Iftekhar, A., Bischoff, J. Improved cryosurgery by use of thermophysical and anti-inflammatory adjuvants. Technology in Cancer Research & Treatment 3, 103-111 (2004). (Pubitemid 38544257)
6. Yu, T.-H., Liu, J., Zhou, Y.-X. Selective freezing of target biological tissues after injection of solutions with specific thermal properties. Cryobiology 50, 174-182 (2005). (Pubitemid 40544335)
7. Ikekawa, S., Ishihara, S., Ikeda, S. Basic Studies of cryo-chemotherapy in a murine tumor system. Cryobiology 22, 477-483 (1985).
8. Benson, J. W. Combined Chemotherapy and Cryosurgery for Oral Cancer. Am J Surg 13, 596-600 (1975).
9. Clarke, D. M., Baust, J. M., Van Buskirk, R. G., Baust, J. G. Chemo-Cryo Combination Therapy: An Adjunctive Model for the Treatment of Prostate Cancer. Cryobiology 42, 274-285, (2001).
10. Mir, L. M., Rubinsky, B. Treatment of Cancer with Cryochemotherapy. British Journal of Cancer 86, 1658-1660 (2002). (Pubitemid 34628123)
11. Le Pivert, P., Haddad, R., Aller, A., Titus, K., Doulat, J., Renard, M., Morrison, D.R. Ultrasound Guided, Combined Cryoablation and Microencapsulated 5-Fluorouracil, Inhibits Growth of Human Prostate Tumors in Xenogenic Mouse Model Assessed by Luminescence Imaging. Technology in Cancer Research & Treatment 3, 135-142 (2004). (Pubitemid 38544260)
12. Caceres, G., Zhu, X. J., Zankina, R., Aller, A., Andreotti, P. Imaging of Luciferase and GFP transfected human tumors in nude mice. Luminescence 18, 1-5 (2003). (Pubitemid 40326820)
13. Morrison, D. R., LePivert, P., Haddad, R. S. Cytotoxic Effects of Microencapsulated 5-FU on Human Prostate Tumor Cells. J. Controlled Release (in preparation, 2008).
14. Elliott, G., Fron, D., McGrath, J., Seip, C., Crockett-Torabi, E. Development of a novel in vivo Assay for Assessment of Tissue viability: A Cryosurgery Application. HTD 368/BED 47, 149-155 (2000).
15. Kuszyk, B., Corl, F., et al. Tumor Transport Physiology: implications for imaging and imaging-guided therapy. AJR 177, 747-753 (2001). (Pubitemid 32881644)
16. Goldberg, E., Hadba, A., Almond, B., Marotta, J. Intratumoral cancer chemotherapy and immunotherapy: opportunities for non systemic preoperative drug delivery. J Pharm Pharmaco 54, 159-180 (2002) (Pubitemid 34150053)
17. Matsushima, Y., Kanzawa, F., Hoshi, A., Shimizu, E., Nomori, H., Sasaki, Y., Saijo, N. Time-schedule dependency of the inhibiting activity of various anticancer drugs in the clonogenic assay. Cancer Chemother Pharmacol 14, 104-107, (1985) (Pubitemid 15164807)
18. Morrison, D. R., Le Pivert, P., Haddad, R. S., Aller, A., Titus, K. Cryochemotherapy of Human Lung Cancer Xenografts (in preparation).
19. Rosenthal, M., Thomas, D., Davis, I., Toner, G., Noordin, N., Zalcberg, J. Pilot Study of Oral Eniluracil/5-FU in the Palliation of Hormone-Refractory Prostate Cancer. The Prostate Journal 3, 30-35 (2001). (Pubitemid 32852831)
20. Kuzel, T. M., Tallman, M. S., Shevrin, D., Braud, E., Kilton, L., Johnson, P., Kozlowski, J., Vogelzang, N. J., Blough, R., Benson, III, A. B. A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An illinois cancer center study. Cancer 72, 1965-1968 (1993). (Pubitemid 23262129)
21. Raghavan, D., Koczwara, B., Javle, M. Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer. Eur J Cancer 33, 566-574 (1997). (Pubitemid 27223739)
22. Pienta, K. and Smith, D. Advances in Prostate Cancer Chemotherapy: A New Era Begins. CA Cancer J Clin 55, 300-318 (2005). (Pubitemid 41377334)
23. Rehman, J., Landman, J., Sundaram, C., Clayman. R. V. Tissue chemoablation. Journal of Endourology 17, 647-657 (2003). (Pubitemid 37362915)